Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
LifeTech Scientific Corporation ( (HK:1302) ) has shared an announcement.
LifeTech Scientific Corporation has updated the market on the composition of its board of directors, confirming Xie Yuehui as executive director, chairman and chief executive officer, alongside executive directors Wu Liping and Fang Yu, non-executive director Jiang Feng, and independent non-executive directors Zhou Luming and Chen Dongxia. The company has also detailed the structure of its three key board committees, with Chen Dongxia chairing both the audit and remuneration committees and Zhou Luming chairing the nomination committee, signaling a continued emphasis on independent oversight and corporate governance for shareholders and other stakeholders.
More about LifeTech Scientific Corporation
LifeTech Scientific Corporation is a Cayman Islands-incorporated medical technology company listed in Hong Kong, focusing on the development and commercialization of cardiovascular and other minimally invasive medical devices. The company targets both domestic and international healthcare markets, supplying interventional products to hospitals and clinics treating heart and vascular diseases.
Average Trading Volume: 21,633,947
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.2B
Learn more about 1302 stock on TipRanks’ Stock Analysis page.